US Stock MarketDetailed Quotes

RCEL Avita Medical

Watchlist
  • 8.730
  • -0.490-5.31%
Close Mar 28 16:00 ET
  • 8.730
  • 0.0000.00%
Post 16:05 ET
230.10MMarket Cap-3.65P/E (TTM)

Avita Medical Key Stats

Avita Medical Q4 2024 Earnings Date

Currency:USDFeb 13, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
19.65M
18.41M
-1.25M
Miss Est.
+33.02%
+29.67%
-6.35%
EPS
-0.48
-0.44
+0.04
Beat Est.
-63.51%
-57.14%
+7.62%
Buy

Feb 28, 2025

Avita Medical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 37.009M--
--2025/Q1-- / 32.767M--
Feb 13, 20252024/Q429.212M / 31.590M--
Nov 7, 20242024/Q329.311M / 29.222M--
Aug 8, 20242024/Q223.124M / 21.981M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 37.009M--
--2025/Q1-- / 32.767M--
Feb 13, 20252024/Q429.212M / 31.590M--
Nov 7, 20242024/Q329.311M / 29.222M--
Aug 8, 20242024/Q223.124M / 21.981M--

Unlock Free Earnings Estimates

Avita Medical Earnings Reports

Read more

Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data